Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1999;34:1232-1236

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Honda, H.
Right arrow Articles by Kogo, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Honda, H.
Right arrow Articles by Kogo, H.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*4-AMINOPYRIDINE
*TESTOSTERONE
Medline Plus Health Information
*High Blood Pressure

(Hypertension. 1999;34:1232.)
© 1999 American Heart Association, Inc.


Scientific Contributions

Different Mechanisms for Testosterone-Induced Relaxation of Aorta Between Normotensive and Spontaneously Hypertensive Rats

Hideo Honda; Tamao Unemoto; Hiroshi Kogo

From the Department of Pharmacology, Tokyo University of Pharmacy and Life Science, Tokyo, Japan.

Correspondence to Hideo Honda, PhD, Department of Pharmacology, Tokyo University of Pharmacy and Life Science, 1432-1, Horinouchi, Hachioji, Tokyo 193-0392, Japan. Email hhonda{at}ps.toyaku.ac.jp

Abstract—The tension in isolated ring preparations of the thoracic aortae from Wistar-Kyoto rats (WKY) and spontaneously hypertensive rats (SHR) was measured isometrically to study the differences in testosterone-induced relaxation between WKY and SHR aortic rings. Testosterone (9 to 300 µmol/L) induced a concentration-dependent relaxation in both WKY and SHR aortic rings, and the relaxation induced by testosterone was greater in SHR than WKY. The relaxation induced by testosterone was significantly reduced by denudation of endothelium in SHR but not WKY. Indomethacin, an inhibitor of cyclooxygenase, and NG-nitro-L-arginine, an inhibitor of nitric oxide (NO) synthase, showed little influence on the relaxation induced by testosterone in both WKY and SHR aortic rings. Glibenclamide, a selective inhibitor of ATP-sensitive potassium channels, significantly reduced the relaxation induced by testosterone in both WKY and SHR aortic rings, although the extent of reduction was greater in WKY than SHR. On the other hand, 4-aminopyridine, a selective inhibitor of voltage-dependent potassium channels, and tetraethylammonium, an inhibitor of calcium-activated potassium channels, significantly reduced the relaxation induced by testosterone in SHR but not WKY. These results suggest that the mechanisms of testosterone-induced vasorelaxation in both WKY and SHR involve, in part, ATP-sensitive potassium channels in the thoracic aortae and that in SHR aortic rings, testosterone may release endothelium-derived substances that may cause hyperpolarization of the cells by a mechanism that involves potassium channels. Moreover, the data show differences between WKY and SHR in the function of ATP-sensitive, voltage-dependent, and calcium-activated potassium channels.


Key Words: testosterone • endothelium • rats, inbred SHR • rats, inbred WKY • aorta • potassium channels




This article has been cited by other articles:


Home page
EndocrinologyHome page
L. M. Montano, E. Calixto, A. Figueroa, E. Flores-Soto, V. Carbajal, and M. Perusquia
Relaxation of Androgens on Rat Thoracic Aorta: Testosterone Concentration Dependent Agonist/Antagonist L-Type Ca2+ Channel Activity, and 5{beta}-Dihydrotestosterone Restricted to L-Type Ca2+ Channel Blockade
Endocrinology, May 1, 2008; 149(5): 2517 - 2526.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
T. S. Cunha, M. Jose, C. S. Moura, C. F. Bernardes, A. P. Tanno, and F. K. Marcondes
Vascular Sensitivity to Phenylephrine in Rats Submitted to Anaerobic Training and Nandrolone Treatment
Hypertension, October 1, 2005; 46(4): 1010 - 1015.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
R. A. Khalil
Sex Hormones as Potential Modulators of Vascular Function in Hypertension
Hypertension, August 1, 2005; 46(2): 249 - 254.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. M. Orshal and R. A. Khalil
Gender, sex hormones, and vascular tone
Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2004; 286(2): R233 - R249.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. J. Gonzales, D. N. Krause, and S. P. Duckles
Testosterone suppresses endothelium-dependent dilation of rat middle cerebral arteries
Am J Physiol Heart Circ Physiol, February 1, 2004; 286(2): H552 - H560.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
P. Y. Liu, A. K. Death, and D. J. Handelsman
Androgens and Cardiovascular Disease
Endocr. Rev., June 1, 2003; 24(3): 313 - 340.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
F. C. W. Wu and A. von Eckardstein
Androgens and Coronary Artery Disease
Endocr. Rev., April 1, 2003; 24(2): 183 - 217.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
A. Q. Ding and J. N. Stallone
Testosterone-induced relaxation of rat aorta is androgen structure specific and involves K+ channel activation
J Appl Physiol, December 1, 2001; 91(6): 2742 - 2750.
[Abstract] [Full Text] [PDF]


Home page
QJMHome page
P.J. Pugh, K.M. English, T.H. Jones, and K.S. Channer
Testosterone: a natural tonic for the failing heart?
QJM, October 1, 2000; 93(10): 689 - 694.
[Full Text] [PDF]